Beyond intravenous delivery: choosing better administration routes for oncologic drugs

Intravenous delivery remains the dominant paradigm in oncology, but even with precision medicine few drugs pass late stage clinical trials. Karthik Chellappan proposes that early exploration of better administration routes could make all the difference.

Constraints imposed by intravenous delivery

What is ‘targeted’ delivery?

Why consider targeted delivery?

In-silico time stepped modelling of drug penetration and dispersion through a tumour following intravenous infusion.

The current landscape of ‘targeted’ delivery devices

Developing a ‘targeted’ delivery device

Conclusion

TTP is an independent technology company where scientists and engineers collaborate to invent, design and develop new products and technologies.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store